These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7270004)

  • 1. Growth hormone and prolactin secretion in liver cirrhosis: evidence for dopaminergic dysfunction.
    Borzio M; Caldara R; Ferrari C; Barbieri C; Borzio F; Romussi M
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):441-7. PubMed ID: 7270004
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolactin secretion in Parkinson disease.
    Eisler T; Thorner MO; MacLeod RM; Kaiser DL; Calne DB
    Neurology; 1981 Oct; 31(10):1356-9. PubMed ID: 6810204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours.
    Jones MK; Ramsay ID; Jenner PG
    Br J Clin Pharmacol; 1978 May; 5(5):425-30. PubMed ID: 656281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dopaminergic receptors in the regulation of growth hormone secretion.
    Müller EE; Liuzzi A; Cocchi D; Panerai AE; Oppizzi G; Lacatelli V; Mantegazza P; Silvestrini F; Chiodini PG
    Adv Biochem Psychopharmacol; 1977; 16():127-38. PubMed ID: 142419
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of blood levels of prolactin and somatotropin as indices of pharmacological effects on the central nervous system].
    Barreca T; Gallamini A; Murialdo G; Nizzo MC; Polleri A
    Clin Ter; 1978 Jul; 86(2):147-59. PubMed ID: 743856
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of carbidopa on prolactin, growth hormone and cortisol secretion in man.
    Brown GM; Garfinkel PE; Warsh JJ; Stancer HC
    J Clin Endocrinol Metab; 1976 Jul; 43(1):236-9. PubMed ID: 947942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lithium on hypothalamic-pituitary dopaminergic function.
    Lal S; Nair NP; Guyda H
    Acta Psychiatr Scand; 1978 Jan; 57(1):91-6. PubMed ID: 636903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
    González LC; Pinilla L; Tena-Sempere M; Aguilar E
    J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin and growth hormone responses to the serotonin antagonist, metergoline, in liver cirrhosis: further evidence for serotoninergic dysfunction.
    Borzio M; Caldara R; Ferrari C; Borzio F; Piepoli V; Romussi M
    Horm Metab Res; 1982 May; 14(5):277-8. PubMed ID: 7095740
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenytoin-induced increase in growth hormone response to levodopa in adult males.
    D'Alessandro R; Cortelli P; Gallassi R; Ghisoli E; Montanaro N; Zoni E; Baruzzi A
    J Neurol Neurosurg Psychiatry; 1984 Jul; 47(7):715-9. PubMed ID: 6431057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: growth hormone and prolactin response to stimuli.
    Brambilla F; Bellodi L; Negri F; Smeraldi E; Malagoli G
    Psychoneuroendocrinology; 1979 Oct; 4(4):329-39. PubMed ID: 523590
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of dopaminergic blockade on the secretion of growth hormone and prolactin in man.
    Masala A; Delitala G; Alagna S; Devilla L; Rovasio PP; Lotti G
    Metabolism; 1978 Aug; 27(8):921-6. PubMed ID: 672613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and prolactin stimulation by Madopar in Parkinson's disease.
    Martinez-Campos A; Giovannini P; Parati E; Novelli A; Caraceni T; Müller EE
    J Neurol Neurosurg Psychiatry; 1981 Dec; 44(12):1116-23. PubMed ID: 7334406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma growth hormone and prolactin response to thyrotropin releasing hormone, L-dopa and luteinizing hormone-releasing hormone in alcoholic patients with liver cirrhosis.
    Zanoboni A; Zanoboni-Muciaccia W; Bonfanti M; Gattei G; Zecca L
    Farmaco Prat; 1980 Sep; 35(9):455-65. PubMed ID: 6778710
    [No Abstract]   [Full Text] [Related]  

  • 15. Carbidopa plus L-dopa pretreatment inhibits the prolactin (PRL) response to thyrotropin-releasing hormone and thus cannot distinguish central from pituitary sites of prolactin stimulation.
    Carlson HE
    J Clin Endocrinol Metab; 1986 Jul; 63(1):249-51. PubMed ID: 3086358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
    Agnoli A; Ruggieri S; Baldassarre M; Rocco A; Del Roscio S; D'Urso R; Mearelli S; Falaschi P; Frajese G
    Prog Clin Biol Res; 1980; 39():215-24. PubMed ID: 6773067
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the abnormal response of pituitary somatotropin to dopaminergic drugs in patients with acromegaly].
    Shi YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):168-72. PubMed ID: 2150352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone secretion in hypertensive patients: evidence for a derangement in central adrenergic function.
    Barbieri C; Ferrari C; Caldara R; Curtarelli G
    Clin Sci (Lond); 1980 Feb; 58(2):135-8. PubMed ID: 7357832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine function in Huntington's disease: dopaminergic regulation of prolactin release.
    Caine E; Kartzinel R; Ebert M; Carter AC
    Life Sci; 1978 Mar; 22(10):911-8. PubMed ID: 147978
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormones, dopamine receptors and schizophrenia.
    Meltzer HY; Busch D; Fang VS
    Psychoneuroendocrinology; 1981; 6(1):17-36. PubMed ID: 7244055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.